These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 30333274

  • 21. Mycophenolate mofetil or standard therapy for membranous nephropathy and focal segmental glomerulosclerosis: a pilot study.
    Senthil Nayagam L, Ganguli A, Rathi M, Kohli HS, Gupta KL, Joshi K, Sakhuja V, Jha V.
    Nephrol Dial Transplant; 2008 Jun; 23(6):1926-30. PubMed ID: 17989103
    [Abstract] [Full Text] [Related]

  • 22. Mycophenolate Mofetil Following Rituximab in Children With Steroid-Resistant Nephrotic Syndrome.
    Basu B, Mahapatra TK, Mondal N.
    Pediatrics; 2015 Jul; 136(1):e132-9. PubMed ID: 26101364
    [Abstract] [Full Text] [Related]

  • 23. Three year outcome of childhood idiopathic nephrotic syndrome under a unified immunosuppressive protocol.
    Hibino S, Uemura O, Nagai T, Yamakawa S, Iwata N, Ito H, Nakano M, Tanaka K.
    Pediatr Int; 2015 Jul; 57(1):85-91. PubMed ID: 25225083
    [Abstract] [Full Text] [Related]

  • 24. High-Dose Rituximab Ineffective for Focal Segmental Glomerulosclerosis: A Long-Term Observation Study.
    Roccatello D, Sciascia S, Rossi D, Alpa M, Naretto C, Radin M, Barreca A, Fenoglio R, Baldovino S, Menegatti E.
    Am J Nephrol; 2017 Jul; 46(2):108-113. PubMed ID: 28700988
    [Abstract] [Full Text] [Related]

  • 25. [Steroid-resistant focal segmental glomerulosclerosis treated with cascade plasmafiltration and rituximab].
    Tatangelo P, Londrino F, Di Vasta G, Guido G, Centi A, Dominijanni S, Bernabei E, Caramiello MS, Di Franco D, Palumbo R.
    G Ital Nefrol; 2018 May; 35(3):. PubMed ID: 29786187
    [Abstract] [Full Text] [Related]

  • 26. Advanced therapeutics in focal and segmental glomerulosclerosis.
    Liu Y, Shi Y, Ren R, Xie J, Wang W, Chen N.
    Nephrology (Carlton); 2018 Oct; 23 Suppl 4():57-61. PubMed ID: 30298667
    [Abstract] [Full Text] [Related]

  • 27. Outcomes of Different Immunosuppressive Regimen in Adult Biopsy Proven Idiopathic Focal Segmental Glomerulosclerosis: A Retrospective Analysis at a Single Center.
    Qureshi R, Nasir K, Imtiaz S, Dhrolia MF, Ahmad A, Salman B.
    Saudi J Kidney Dis Transpl; 2022 Oct; 33(1):111-121. PubMed ID: 36647985
    [Abstract] [Full Text] [Related]

  • 28. Nephrotic syndrome with focal segmental glomerulosclerosis after an insect bite.
    Révai T, Kaszás I, Márton C, Arpási G, Winkler G.
    Clin Nephrol; 2006 Aug; 66(2):128-30. PubMed ID: 16939069
    [Abstract] [Full Text] [Related]

  • 29. Fifteen-year remission of a steroid-resistant nephrotic syndrome sustained by cyclosporine A.
    Drube J, Geerlings C, Taylor R, Mengel M, Ehrich JH.
    Pediatr Nephrol; 2007 Apr; 22(4):600-2. PubMed ID: 17235550
    [Abstract] [Full Text] [Related]

  • 30. Ofatumumab in post-transplantation recurrence of focal segmental glomerulosclerosis in a child.
    Solomon S, Zolotnitskaya A, Del Rio M.
    Pediatr Transplant; 2019 Jun; 23(4):e13413. PubMed ID: 30973669
    [Abstract] [Full Text] [Related]

  • 31. Rituximab and chronic plasmapheresis therapy of nephrotic syndrome in renal transplantation patients with recurrent focal segmental glomerulosclerosis.
    Rodríguez-Ferrero M, Ampuero J, Anaya F.
    Transplant Proc; 2009 Jun; 41(6):2406-8. PubMed ID: 19715934
    [Abstract] [Full Text] [Related]

  • 32. Complete remission of nephrotic syndrome in an infant with focal segmental glomerulosclerosis: is it renin-angiotensin blockade?
    Soliman NA, Francis M, Heeringa SF, Chernin G.
    Pediatr Nephrol; 2009 May; 24(5):1065-70. PubMed ID: 18853198
    [Abstract] [Full Text] [Related]

  • 33. Rituximab for refractory focal segmental glomerulosclerosis.
    Nakayama M, Kamei K, Nozu K, Matsuoka K, Nakagawa A, Sako M, Iijima K.
    Pediatr Nephrol; 2008 Mar; 23(3):481-5. PubMed ID: 17973121
    [Abstract] [Full Text] [Related]

  • 34. Immunosuppressive treatment of idiopathic focal segmental glomerulosclerosis: a five-year follow-up study.
    Goumenos DS, Tsagalis G, El Nahas AM, Shortland JR, Davlouros P, Vlachojannis JG, Brown CB.
    Nephron Clin Pract; 2006 Mar; 104(2):c75-82. PubMed ID: 16785738
    [Abstract] [Full Text] [Related]

  • 35. Rituximab for post-transplant recurrences of FSGS.
    Bayrakci US, Baskin E, Sakalli H, Karakayali H, Haberal M.
    Pediatr Transplant; 2009 Mar; 13(2):240-3. PubMed ID: 18822107
    [Abstract] [Full Text] [Related]

  • 36. Cyclosporine-based immunosuppressive therapy for patients with steroid-resistant focal segmental glomerulosclerosis: a meta-analysis.
    Chiou YY, Lee YC, Chen MJ.
    Curr Med Res Opin; 2017 Aug; 33(8):1389-1399. PubMed ID: 28436233
    [Abstract] [Full Text] [Related]

  • 37. Rituximab therapy for refractory steroid-resistant nephrotic syndrome in children.
    Kamei K, Ishikura K, Sako M, Ito S, Nozu K, Iijima K.
    Pediatr Nephrol; 2020 Jan; 35(1):17-24. PubMed ID: 30564879
    [Abstract] [Full Text] [Related]

  • 38. Low-density lipoprotein apheresis in a pediatric patient with refractory nephrotic syndrome due to focal segmental glomerulosclerosis.
    Oto J, Suga K, Matsuura S, Kondo S, Ohnishi Y, Inui D, Imanaka H, Kagami S, Nishimura M.
    J Anesth; 2009 Jan; 23(2):284-7. PubMed ID: 19444573
    [Abstract] [Full Text] [Related]

  • 39. [Focal and segmental glomerulosclerosis in Piedmont and the Aosta Valley in Italy: case study and treatment].
    Rollino C, Giacchino F, Savoldi S, Manganaro M, Besso L, Amore A, Ferro M, Quaglia M.
    G Ital Nefrol; 2013 Jan; 30(3):. PubMed ID: 23832471
    [Abstract] [Full Text] [Related]

  • 40. Treatment of focal segmental glomerular sclerosis with rituximab: 2 case reports.
    Kamar N, Faguer S, Esposito L, Guitard J, Nogier MB, Durand D, Rostaing L.
    Clin Nephrol; 2007 Apr; 67(4):250-4. PubMed ID: 17474562
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.